Rheumatology News

Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with rheumatoid arthritis, according to data published in RMD Open.

Developing myalgic encephalomyelitis/chronic fatigue syndrome is significantly more likely after a case of COVID-19, an important connection for rheumatologists as they sort through symptoms and medical histories for a diagnosis, data show.

Systemic sclerosis appears to have a “non-random” occurrence across the United States, with clusters of people diagnosed around environmentally contaminated Superfund sites, according to data published in Arthritis Care & Research.

Although chimeric antigen receptor T-cell therapy has raised hopes for long-term remission in autoimmune disease, it has several limitations that may be overcome instead through bispecific T-cell-engaging antibodies, according to a speaker.

A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the long-term, drug-free remission from autoimmune diseases observed after treatment, according to a speaker.

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference product manufacturer, Janssen Pharmaceuticals, which set timelines for their market entries.

Black patients, particularly women, have died from systemic lupus erythematosus at disproportionately higher rates despite overall declines in mortality over the past 20 years, according to data published in Arthritis Care & Research.

The approval of etanercept for juvenile idiopathic arthritis in 1999 heralded a new era for children with arthritis. However, despite subsequent approvals for JIA, many patients with other types of childhood arthritis remain without options.

Prior authorization reforms, increased biosimilar access and the future of the Medicare drug price negotiation program are among the American College of Rheumatology’s top concerns in a letter recently submitted to CMS.

In part 2, we dig into the history of pulmonary hypertension. How did this strange diagnosis first get recognized, what does it have to do with cows with thick necks and urinary catheters in the heart?